Cronos Group Inc. (CRON)

10.29
NASDAQ : Process Industries
Prev Close 10.23
Day Low/High 10.04 / 10.47
52 Wk Low/High 6.50 / 25.10
Avg Volume 3.94M
Exchange NASDAQ
Shares Outstanding 341.24M
Market Cap 3.50B
EPS -0.10
P/E Ratio 30.97
Div & Yield N.A. (N.A)

Latest News

Cronos Group Could Break Key Moving Averages - Protect Long Positions

Cronos Group Could Break Key Moving Averages - Protect Long Positions

Let's look at the chart of CRON.

Morningstar High on Pot Growth, Sees U.S. Going Legal by 2023

Morningstar High on Pot Growth, Sees U.S. Going Legal by 2023

Analysts say nation will turn a new leaf, changing federal law within a few years, as cannabis industry expected to grow big time over next decade.

Would You Rather Have an Executive Team Managing the Company or the Stock Price?

Would You Rather Have an Executive Team Managing the Company or the Stock Price?

It all comes down to matching my time frame.

OrganiGram Could Climb Higher, but You Need Discipline Before Buying

OrganiGram Could Climb Higher, but You Need Discipline Before Buying

Here's how to play OGI stock right now.

5 Cannabis ETFs to Fire Up Your Portfolio

5 Cannabis ETFs to Fire Up Your Portfolio

Two of them are brand new.

Prohibition and the Paradoxical Proclivity of Cannabis Consumption

Prohibition and the Paradoxical Proclivity of Cannabis Consumption

Is prohibition the real factor propping up projections for demand and pricing in the cannabis market?

Should Investors Buy the Dip in Canopy Growth Stock?

Should Investors Buy the Dip in Canopy Growth Stock?

Canopy's earnings losses could just be a stepping stone to becoming the industry leader.

Canopy Growth Now Has to be Considered the Leader in the Canadian Cannabis Space

Canopy Growth Now Has to be Considered the Leader in the Canadian Cannabis Space

CGC has the best chance to transition to broader success should the U.S. ever go the route of legalization beyond the state level.

Cronos Group's High Times May Be About to Wear Off

Cronos Group's High Times May Be About to Wear Off

Charts of this type are frequently found to be topping patterns.

Altria or Philip Morris International: Which Is the Better Dividend Stock?

Altria or Philip Morris International: Which Is the Better Dividend Stock?

While the two tobacco giants have similar yields, both also have very different businesses, with different growth potential in the years ahead.

Use Caution on Small-Caps, Plus Apple, Tesla and McDonald's: Market Recon

Use Caution on Small-Caps, Plus Apple, Tesla and McDonald's: Market Recon

Equity markets marked time on Monday, mostly on light volume.

Cronos Group Certainly Qualifies for Mainstream Consideration

Cronos Group Certainly Qualifies for Mainstream Consideration

Revenue is where it's at for cannabis in 2019.

2 Big Earnings Reports I'll Be Watching This Week

2 Big Earnings Reports I'll Be Watching This Week

A huge week is coming up for these well-known stocks.

7 Indirect Stock Plays on the Cannabis Sector

7 Indirect Stock Plays on the Cannabis Sector

Investors can gain exposure to the high-flying cannabis industry without taking on undue risks.

Short Interest Monitor on Tilray

Tilray Stock Lights Up as Partnerships Obscure Profitability Problem

Tilray Stock Lights Up as Partnerships Obscure Profitability Problem

The move was helped by the TLRY's deals with AB InBev for beverages and Novartis for medical applications.

Chart of the Day: Vetting the Value of Cannabis Companies

Chart of the Day: Vetting the Value of Cannabis Companies

Assessing Aurora and its peers, strictly on the numbers.

Jim Cramer: AAPL Should Get Into Diabetes Treatment and KHC Should Invest in Pot

Jim Cramer: AAPL Should Get Into Diabetes Treatment and KHC Should Invest in Pot

In this day and age, companies must be 'disruptors' or get left in the dust.

Peltz Is the Perfect Problem Solver for Aurora Cannabis

Peltz Is the Perfect Problem Solver for Aurora Cannabis

Peltz's addition should pacify a persistent critique of the company.

Just How Hot Is Cannabis?

Jim Cramer: Buy Aurora Cannabis Because Nelson Peltz Knows What Can Go Right

Jim Cramer: Buy Aurora Cannabis Because Nelson Peltz Knows What Can Go Right

I know that Nelson is fascinated by the medicinal properties chiefly as a replacement for opioids, the scourge of this country.

Nelson Peltz Could Be Key to Cannabis in Consumer Packaged Goods

Nelson Peltz Could Be Key to Cannabis in Consumer Packaged Goods

Aurora's prominent partner could be cannabis' key to breaking into consumer segments.

Melius Research Launches Cannabis Industry Coverage

Melius Research Launches Cannabis Industry Coverage

In its first report on cannabis companies, Melius says prices are high.

Can Cronos Group Soar Higher? Looks Like it

Can Cronos Group Soar Higher? Looks Like it

The stock price of the cannabis company has been on a roll and is poised to move even higher still.

Jim Cramer: My Best Stock Picks for Cannabis and China

Jim Cramer: My Best Stock Picks for Cannabis and China

And why I won't recommend any other stocks in these markets, right now.

Short-Selling Is Really Hard. Just Ask Citron Research

Short-Selling Is Really Hard. Just Ask Citron Research

Examining the influential short-sellers' big winners and losers provides important insights into trading and investing.